{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:09:47Z","timestamp":1787882987507,"version":"build-2784847793"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,9]]},"DOI":"10.7759\/cureus.24857","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T18:06:23Z","timestamp":1652119583000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Aggressive Peripheral T-cell Lymphoma\u2013Not Otherwise Specified"],"prefix":"10.7759","author":[{"given":"Ateeb Ur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Chaudary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Varandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger DD","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, et al.. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011, 117:3402-8. 10.1182\/blood-2010-09-310342","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"23","author":"Foss FM","year":"2011","unstructured":"Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K. Peripheral T-cell lymphoma. Blood. 2011, 23:6756-67. 10.1182\/blood-2010-05-231548","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose J","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008, 26:4124-30. 10.1200\/JCO.2008.16.4558","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0582-9","article-title":"Genetic landscape and classification of peripheral t cell lymphomas","volume":"19","author":"Sandell RF","year":"2017","unstructured":"Sandell RF, Boddicker RL, Feldman AL. Genetic landscape and classification of peripheral t cell lymphomas. Curr Oncol Rep. 2017, 19:28. 10.1007\/s11912-017-0582-9","journal-title":"Curr Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-516245","article-title":"How I treat the peripheral T-cell lymphomas","volume":"123","author":"Moskowitz AJ","year":"2014","unstructured":"Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood. 2014, 123:2636-44. 10.1182\/blood-2013-12-516245","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1045897","article-title":"The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"57","author":"Beltran BE","year":"2016","unstructured":"Beltran BE, Aguilar C, Qui\u00f1ones P, Morales D, Chavez JC, Sotomayor EM, Castillo JJ. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016, 57:58-62. 10.3109\/10428194.2015.1045897","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21589","article-title":"The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management","volume":"70","author":"Marchi E","year":"2020","unstructured":"Marchi E, O'Connor OA. The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management. CA Cancer J Clin. 2020, 70:47-70. 10.3322\/caac.21589","journal-title":"CA Cancer J Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001821","article-title":"Brentuximab vedotin in the treatment of CD30+ PTCL","volume":"134","author":"Barta SK","year":"2019","unstructured":"Barta SK, Gong JZ, Porcu P. Brentuximab vedotin in the treatment of CD30+ PTCL. Blood. 2019, 134:2339-45. 10.1182\/blood.2019001821","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79560-a-rare-case-of-aggressive-peripheral-t-cell-lymphoma-not-otherwise-specified","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:43Z","timestamp":1707507703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79560-a-rare-case-of-aggressive-peripheral-t-cell-lymphoma-not-otherwise-specified"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.24857","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}